Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Connie M. Szczepanek"'
Autor:
Han-Mo Koo, George F. Vande Woude, Gabriela Bedolla, Alan T. Davis, Matthew W. Van Brocklin, Phyllis Stein, Kimberly J. Truszkowski, Michelle R. Bassett, Connie M. Szczepanek, Kathleen J. Yost, Timothy J. O'Rourke, Thomas J. Monroe, Alan D. Campbell, Charles R. Luttenton, Patrick J. Richardson, Craig P. Webb, Marianne K. Melnik
Supplementary Table 1 from Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c864040888e732f9c20c2310c5c261
https://doi.org/10.1158/1535-7163.22485188
https://doi.org/10.1158/1535-7163.22485188
Autor:
Han-Mo Koo, George F. Vande Woude, Gabriela Bedolla, Alan T. Davis, Matthew W. Van Brocklin, Phyllis Stein, Kimberly J. Truszkowski, Michelle R. Bassett, Connie M. Szczepanek, Kathleen J. Yost, Timothy J. O'Rourke, Thomas J. Monroe, Alan D. Campbell, Charles R. Luttenton, Patrick J. Richardson, Craig P. Webb, Marianne K. Melnik
Prior studies suggest that tumor cell lines harboring RAS mutations display remarkable sensitivity to gemcitabine and etoposide. In a phase II clinical trial of patients with locally advanced or metastatic pancreatic cancer, we evaluated the response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ac05d7f09bbf7f596f622d484a34674
https://doi.org/10.1158/1535-7163.c.6531824.v1
https://doi.org/10.1158/1535-7163.c.6531824.v1
Autor:
Han-Mo Koo, George F. Vande Woude, Gabriela Bedolla, Alan T. Davis, Matthew W. Van Brocklin, Phyllis Stein, Kimberly J. Truszkowski, Michelle R. Bassett, Connie M. Szczepanek, Kathleen J. Yost, Timothy J. O'Rourke, Thomas J. Monroe, Alan D. Campbell, Charles R. Luttenton, Patrick J. Richardson, Craig P. Webb, Marianne K. Melnik
Supplementary Form 1 from Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2caef588d4459fa29ca578f040067ac9
https://doi.org/10.1158/1535-7163.22485191.v1
https://doi.org/10.1158/1535-7163.22485191.v1
Autor:
Jack O. Hensold, Jonathan M. Marron, Nathan A. Pennell, Brian Bourbeau, Piyush Srivastava, Gladys Rodriguez, Jonathan K. Phillips, Cardinale B. Smith, Timothy L. Cannon, Eleonora Teplinsky, Stephen Grubbs, Richard L. Schilsky, Theresa M. McDonnell, E. Allyn Moushey, Mithat Gonen, Howard A. Burris, Kurt R. Oettel, Barbara L. McAneny, Caroline Schenkel, Suanna S. Bruinooge, Laura A. Levit, Jane Perlmutter, Sibel Blau, Maximilian Diehn, Barry Russo, Melissa S. Dillmon, Stacie Lindsey, Allison Magnuson, Tiffany A. Traina, Debra A. Patt, Ramya Thota, Natalie R. Dickson, Maria Magdalena Gonzalez, Robin Zon, Tari A. King, Deborah Y. Kamin, Connie M. Szczepanek, Ajjai Alva, Grzegorz S. Nowakowski, Leslie Hinyard, Abby R. Rosenberg, Shelagh E. Foster, Patricia Hurley, Manali I. Patel, Kathryn Finch Mileham, Shelley Fuld Nasso, Todd A. Pickard, Karen L. Hagerty
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(2)
This report presents the American Society of Clinical Oncology’s (ASCO’s) evaluation of the adaptations in care delivery, research operations, and regulatory oversight made in response to the coronavirus pandemic and presents recommendations for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b31dc034aefe5d1939e621998838d173
https://pubmed.ncbi.nlm.nih.gov/33290128
https://pubmed.ncbi.nlm.nih.gov/33290128
Autor:
Patricia Hurley, Marjorie J. Good, Kelly Willenberg, Dax Kurbegov, Casey Dawson, Andrea Denicoff, Connie M. Szczepanek
Publikováno v:
Journal of oncology practice. 13(6)
Purpose: Clinical trial billing compliance is a challenge that is faced by overburdened clinical trials sites. The requirements place institutions and research sites at increased potential for financial risk. To reduce their risk, sites develop a cov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c28378b65567797700a15295e08ed847
https://pubmed.ncbi.nlm.nih.gov/28481681
https://pubmed.ncbi.nlm.nih.gov/28481681
Autor:
Rogerio Lilenbaum, Kaitlin M. Woo, Connie M. Szczepanek, Patricia Hurley, Mithat Gonen, Nicholas Robert, Marjorie J. Good, Alan Lyss, Teresa L. Stewart
Publikováno v:
Journal of oncology practice. 12(5)
Purpose: Clinical research program managers are regularly faced with the quandary of determining how much of a workload research staff members can manage while they balance clinical practice and still achieve clinical trial accrual goals, maintain da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ad1e69ded0a93095b54bfe911fbf840
https://pubmed.ncbi.nlm.nih.gov/27006354
https://pubmed.ncbi.nlm.nih.gov/27006354
Autor:
Michael M. Lieber, Anne Ryan, Scott M. Lippman, R. Duane Cespedes, Gary J. Miller, Susie M. Carlin, Leslie G. Ford, Phyllis J. Goodman, M. Scott Lucia, Charles A. Coltman, Connie M. Szczepanek, Catherine M. Tangen, JN Atkins, John Crowley, Ian M. Thompson
Publikováno v:
New England Journal of Medicine. 349:215-224
background Androgens are involved in the development of prostate cancer. Finasteride, an inhibitor of 5 a -reductase, inhibits the conversion of testosterone to dihydrotestosterone, the primary androgen in the prostate, and may reduce the risk of pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed84d69cafcd1fe93311f335c50cb017
https://doi.org/10.1056/nejmoa030660
https://doi.org/10.1056/nejmoa030660
National coverage analyses for NCI clinical trials: A pilot project to reduce participation barriers
Autor:
Casey Dawson, Andrea Denicoff, Sara McCartney, Michael Kelly, Marjorie J. Good, Connie M. Szczepanek, Michael Montello, Julie Kardell, Kathleen R Hurtado, Grace Mishkin, Margaret M. Mooney, Lucille Patrichuk, Kelly Willenberg, Lawrence R. Ragard, Jeffrey S. Abrams, Debra L Strandberg, Morgen Alexander-Young, Mary Beth Sullivan, Worta McCaskill-Stevens
Publikováno v:
Journal of Clinical Oncology. 35:6542-6542
6542 Background: Since the implementation of the ACA, many insurers have followed Medicare’s lead in covering routine care costs associated with clinical trials (CTs). However, questions remain on how to distinguish routine care from non-billable r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd9de001d1305bc72ae65f8384270379
https://doi.org/10.1200/jco.2017.35.15_suppl.6542
https://doi.org/10.1200/jco.2017.35.15_suppl.6542
Autor:
Alan T. Davis, Phyllis Stein, Michelle R. Bassett, Timothy J. O'Rourke, Thomas Monroe, Matthew W. Van Brocklin, Kathleen J. Yost, Kimberly J. Truszkowski, Han Mo Koo, Alan D. Campbell, Charles R. Luttenton, Connie M. Szczepanek, Gabriela M Bedolla, Patrick J. Richardson, Marianne Melnik, Craig P. Webb, George F. Vande Woude
Publikováno v:
Molecular cancer therapeutics. 9(8)
Prior studies suggest that tumor cell lines harboring RAS mutations display remarkable sensitivity to gemcitabine and etoposide. In a phase II clinical trial of patients with locally advanced or metastatic pancreatic cancer, we evaluated the response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d62fd2d64616b4432e9f12cf23fd3e1
https://pubmed.ncbi.nlm.nih.gov/20682649
https://pubmed.ncbi.nlm.nih.gov/20682649